Publicaciones en las que colabora con Antoni Bayes Genis (7)

2020

  1. Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status (Scientific Reports, (2020), 10, 1, (13553), 10.1038/s41598-020-70454-8)

    Scientific Reports

  2. Differences in the Interleukin-1β/Soluble ST2 Interplay Between Acute and Chronic Heart Failure

    Journal of Cardiovascular Translational Research

2019

  1. Reply: Interleukin-1β and sST2

    Journal of the American College of Cardiology

  2. The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure

    Journal of the American College of Cardiology, Vol. 73, Núm. 9, pp. 1016-1025

  3. Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes

    JACC: Basic to Translational Science, Vol. 4, Núm. 7, pp. 831-840

  4. Yin-Yang 1 transcription factor modulates ST2 expression during adverse cardiac remodeling post-myocardial infarction

    Journal of Molecular and Cellular Cardiology, Vol. 130, pp. 216-233

2011

  1. Soluble ST2 is a marker for acute cardiac allograft rejection

    Annals of Thoracic Surgery, Vol. 92, Núm. 6, pp. 2118-2124